Cargando…
Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo
The Kelch-like erythroid-associated protein 1 (Keap1)–NF-E2-related factor 2 (Nrf2) signaling pathway is the subject of several clinical trials evaluating the effects of Nrf2 activation on the prevention of cancer and diabetes and the treatment of chronic kidney disease and multiple sclerosis. 3H-1,...
Autores principales: | Wible, Ryan S., Tran, Quynh T., Fathima, Samreen, Sutter, Carrie H., Kensler, Thomas W., Sutter, Thomas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832324/ https://www.ncbi.nlm.nih.gov/pubmed/29367259 http://dx.doi.org/10.1124/mol.117.110262 |
Ejemplares similares
-
NRF2 regulates core and stabilizing circadian clock loops, coupling redox and timekeeping in Mus musculus
por: Wible, Ryan S, et al.
Publicado: (2018) -
Chemical genomics of cancer chemopreventive dithiolethiones
por: Tran, Quynh T., et al.
Publicado: (2009) -
KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
por: Dinkova-Kostova, Albena T., et al.
Publicado: (2017) -
Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism
por: Chartoumpekis, Dionysios V., et al.
Publicado: (2015) -
New Player on An Old Field; the Keap1/Nrf2 Pathway as a Target for Treatment of Type 2 Diabetes and Metabolic Syndrome
por: Chartoumpekis, Dionysios V, et al.
Publicado: (2013)